Tag: HBV
-
Identification of Novel TERT Promoter Mutations in Chronic Hepatitis B
Introduction Chronic Hepatitis B infection remains a major global health challenge, with a well-established link to hepatocellular carcinoma (HCC). Recent research has turned its attention to the telomerase reverse transcriptase (TERT) promoter, a genomic region that regulates telomerase activity and cellular immortality. While TERT promoter mutations have been documented in various cancers, their role in…
-
Health Screening Campaign Reaches 3 Rural Communities in Upper West Region
Health Screening Campaign Reaches Three Rural Communities in Upper West Region A dedicated health awareness and screening campaign focusing on Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) has expanded its outreach to three rural communities in Jirapa Municipality, located in the Upper West Region. The initiative, led by Sahara…
-
Health Screening Campaign Tests Over 600 in Upper West Communities
Overview of the Campaign A health awareness and screening campaign focusing on HIV, Hepatitis B (HBV), and Hepatitis C (HCV) has delivered concrete results in the Uppe r West Region of Ghana. The initiative, led by Sahara Advocates and supported by local health authorities, successfully screened over 600 residents across three rural communities in the…
-
Sero-prevalence of Hepatitis B Virus Infection and Associated Factors Among Pregnant Women Attending Antenatal Care in Babile District, Eastern Ethiopia
Introduction Hepatitis B virus (HBV) remains a critical global public health challenge, with an estimated 254 million people living with HBV infection as of 2022. In sub-Saharan Africa, HBV prevalence among pregnant women varies widely, prompting urgent calls for routine antenatal screening and strengthened prevention of mother-to-child transmission (PMTCT). This article summarizes a study conducted…
-
Sero-prevalence of Hepatitis B Virus Infection Among Pregnant Women in Babile District, Eastern Ethiopia: Associated Factors and Implications for ANC Programs
Introduction Hepatitis B virus (HBV) remains a major global public health challenge, with an estimated 254 million people living with chronic HBV infection worldwide as of 2022. Mother-to-child transmission (MTCT) is a key driver of chronic HBV cases, particularly in high-endemic regions. In sub-Saharan Africa, prevalence among pregnant women varies widely, underscoring the need for…
-
Low HBV Reactivation Risk After Tenofovir Withdrawal in People with HIV: New EACS 2025 Findings
Background: Tenofovir and HBV in HIV Care Tenofovir has been a cornerstone of antiretroviral therapy (ART) for people living with HIV, partly because it also provides activity against hepatitis B virus (HBV). For patients with past HBV exposure who are virologically suppressed, clinicians have explored strategies to reduce long-term drug toxicity—especially renal and bone side…
-
Low Risk of HBV Reactivation After Tenofovir Withdrawal in People With HIV
New evidence supports safety of tenofovir-sparing ART in HBV-immune people with HIV Emerging data presented at the 2025 European AIDS Clinical Society (EACS) Congress suggest that stopping tenofovir in people with HIV who have prior hepatitis B exposure poses a very small risk of hepatitis B virus (HBV) reactivation. The findings come from the Swiss…
-
What India Can Learn from Maldives’ Triple Elimination of Mother-to-Child Infections
Carving a path from Maldives to India On October 13, 2025, the World Health Organization confirmed that the Republic of Maldives became the first country to eliminate mother-to-child transmission (EMTCT) of HIV, syphilis, and Hepatitis B. While Maldives’ population is small and geographically discreet, the core principles behind its achievement offer actionable lessons for India’s…
-
What India Can Learn from Maldives’ Triple Elimination of Mother-to-Child Transmission
Introduction: A landmark in public health On October 13, 2025, the World Health Organization (WHO) validated the Republic of Maldives as the first country to eliminate mother-to-child transmission (EMTCT) of HIV, syphilis, and Hepatitis B virus (HBV). This triple elimination marks a historic achievement: transmission from mothers to newborns for all three infections has fallen…
-
What India Can Learn From Maldives’ Triple Elimination of Parent-to-Child Transmission
Introduction: A landmark achievement with global relevance On October 13, 2025, the World Health Organization (WHO) celebrated a historic milestone: the Republic of Maldives became the first country to eliminate mother-to-child transmission (EMTCT) of HIV, syphilis, and Hepatitis B virus (HBV). This validation, endorsed by the WHO Director-General after rigorous review, marks the first time…